72 related articles for article (PubMed ID: 9541667)
21. [Superiority of letrozole compared with tamoxifen as first line therapy of postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group].
Illiger HJ
Strahlenther Onkol; 2002 Feb; 178(2):111-3. PubMed ID: 11942036
[No Abstract] [Full Text] [Related]
22. A case of brain metastases from breast cancer that responded to anastrozole monotherapy.
Ito K; Ito T; Okada T; Watanabe T; Gomi K; Kanai T; Mochizuki Y; Amano J
Breast J; 2009; 15(4):435-7. PubMed ID: 19470131
[No Abstract] [Full Text] [Related]
23. [Aromatase inhibitors in the treatment of breast cancer].
Perey L
Rev Med Suisse Romande; 2000 Jun; 120(6):495-500. PubMed ID: 11014093
[No Abstract] [Full Text] [Related]
24. Latest studies hint at survival advantage with aromatase inhibitors in early breast cancer.
Tuma RS
J Natl Cancer Inst; 2006 Jan; 98(2):86-7. PubMed ID: 16418506
[No Abstract] [Full Text] [Related]
25. [Extended adjuvant hormone therapy (in breast cancer): Why? To whom? What? How long?].
Kahán Z
Magy Onkol; 2008 Jun; 52(2):225-6. PubMed ID: 18640899
[No Abstract] [Full Text] [Related]
26. New options in the prevention and treatment of breast carcinoma.
Galleshaw J
J Med Assoc Ga; 2003; 92(1):19-22. PubMed ID: 12743901
[No Abstract] [Full Text] [Related]
27. Anastrozole (Arimidex).
Wilkinson K
Clin J Oncol Nurs; 2004 Feb; 8(1):87-8. PubMed ID: 14983769
[No Abstract] [Full Text] [Related]
28. Regression of choroidal metastases from breast carcinoma using aromatase inhibitors.
Manquez ME; Shields CL; Karatza EC; Shields JA
Br J Ophthalmol; 2005 Jun; 89(6):776-7. PubMed ID: 15923523
[No Abstract] [Full Text] [Related]
29. A step too far?
Lancet Oncol; 2005 Oct; 6(10):731. PubMed ID: 16198972
[No Abstract] [Full Text] [Related]
30. New aromatase inhibitors: more selectivity, less toxicity, unfortunately, the same activity.
Castiglione-Gertsch M
Eur J Cancer; 1996 Mar; 32A(3):393-5. PubMed ID: 8814679
[No Abstract] [Full Text] [Related]
31. Clarification of anastrozole/megestrol acetate trial program design.
Howell A
J Clin Oncol; 2000 Dec; 18(24):4109. PubMed ID: 11118472
[No Abstract] [Full Text] [Related]
32. New alternative to tamoxifen.
Harv Womens Health Watch; 2002 Jul; 9(11):7. PubMed ID: 12138025
[No Abstract] [Full Text] [Related]
33. Letrozole in breast cancer.
Hietanen P; Mäkelä M
N Engl J Med; 2004 Feb; 350(7):727-30; author reply 727-30. PubMed ID: 14971057
[No Abstract] [Full Text] [Related]
34. Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Buzdar A; Howell A
Clin Cancer Res; 2001 Sep; 7(9):2620-35. PubMed ID: 11555572
[No Abstract] [Full Text] [Related]
35. [Summit meeting of breast cancer experts--many new ideas and practical progress. When the breast becomes malignant].
Aumiller J
MMW Fortschr Med; 2003 Jan; 145(3-4):4-8. PubMed ID: 12619224
[No Abstract] [Full Text] [Related]
36. Breast cancer chemoprevention: little progress in practice?
Cameron DA
Lancet; 2014 Mar; 383(9922):1018-20. PubMed ID: 24333008
[No Abstract] [Full Text] [Related]
37. Aromatase inhibitors in the treatment of advanced breast cancer. Introduction.
Osborne CK
Semin Oncol; 1996 Aug; 23(4 Suppl 9):1. PubMed ID: 8824458
[No Abstract] [Full Text] [Related]
38. Aromatase inhibitors and breast cancer.
Miller WR
Cancer Treat Rev; 1997 May; 23(3):171-87. PubMed ID: 9251721
[No Abstract] [Full Text] [Related]
39. Aromatase inhibitors--where are we now?
Miller WR
Br J Cancer; 1996 Feb; 73(4):415-7. PubMed ID: 8595151
[No Abstract] [Full Text] [Related]
40. Indian firm caught marketing anticancer drug for fertility.
Sharma DC
Lancet; 2003 Oct; 362(9390):1128. PubMed ID: 14552336
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
